Watch Ticker

Marker Therapeutics, Inc. Common Stock

Go to Marker Therapeutics, Inc. Common Stock Website

$1.23

-0.02 (-1.61%)

Live

Previous Close

$1.25

Day Range

$1.2 - $1.2726

Previous Day Range

$1.226042 - $1.33

Market Cap

$14.0 million USD

Day Vol.

87811

Previous Day Vol.

108900

Currency

USD

Primary Exchange

Nasdaq

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma

Marker Therapeutics and Cellipont Bioservices have announced a collaboration to advance the cGMP manufacturing of MT-601, Marker's multi-antigen recognizing T cell therapy for lymphoma patients. The collaboration aims to accelerate clinical supply and lay the foundation for a potential pivotal trial and commercial readiness.

Related tickers: MRKR.

Read Full Article

N/A - Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

Marker Therapeutics, a clinical-stage immuno-oncology company, announced that its President and CEO will present at the Citizens JMP Hematology and Oncology Summit on December 2, 2024. The presentation will provide an overview of the company's technology and clinical developments.

Related tickers: MRKR.

Read Full Article

Trending Tickers

Please sign in to view